Many thanks to eyeforpharma Philadelphia for the opportunity to discuss the importance of moving disease care to health care; here’s to a future hashtag#worldwithoutdisease http://bit.ly/efpPHL hashtag#efpphilly hashtag#healthinnovation
Access is now everybody’s business. From clinical through commercial, executives must adjust their strategy to the rapidly changing access environment in the USA.
We need company-wide appreciation of how RWE can determine better value propositions, we must all align to shifting customer desires to focus on early detection and prevention, and we must consider ourselves in alignment or even partnership with payers. Most importantly, everyone must align to the simple premise that the only way medicines improve lives is if patients can actually access them.
For that reason, our agenda contains influencers from a broader group than ever before: patient groups, providers, academia, pharma and industry bodies, we have sourced the ingredients for a revolution in access that delivers a roadmap for sustainable innovation.
Carefully selected to cover every aspect of your market access strategy.
Chris Leibman SVP, Value and Access Biogen
Robert W. Dubois CSO & EVP National Pharmaceutical Council
Sarah Emond EVP and COO ICER
Timothy Paine VP, Pharma Strategy & Relations Fairview Specialty Pharmacy
Scott Howell VP and Head, US Market Access, Pharmaceuticals Novartis
Jay Newman Head of US Marketing and Patient Access Spark Therapeutics, Inc.
Ensure patients can access innovation: Hear ICER, MITDIGGs and the National Pharmaceutical Council unpack realistic strategies for a sustainable value model
Demonstrate value through evidence: Help your customers distinguish the value of RWE and create the infrastructure
Partner with providers: Reframe your priorities through our executive-led IDN panel where they will be setting key priorities where customers want to get to work with you
Level up your value strategy with AI: Use outcomes data to create personalized value propositions for providers and discover new working areas to improve quality of care
Executive Director,The expertise of the speaker faculty and the highly relevant agenda made the conference an invaluable opportunity for learning
North America’s No1 Access conference
A dedicated stream bringing together market access, RWE and medical affairs experts together for the most holistic discussion in North America.
Old friends and new encounters
The only event that brings together leading market access decision-makers plus 1000 attendees from across clinical development, medical affairs, RWE, patient engagement and commercial roles.
Technology is the star of the show
From big names, such as Google and Flatiron Health, to leading pharma and disruptive start-ups – the 7 streams alongside this market track, will be packed with the latest use cases of AI, ML, AR, VR, blockchain and more.
Commercial & Sales Connect to customers through intelligent engagement and empathetic partnerships
RWE & Data Science Let's optimize and accelerate our industry with a vision that powers strategy with evidence and insights
Patient Engagement Destroy tokenism by providing meaningful and measurable value to patients
The Innovation Stage Get yourself out of your comfort zone to explore the new frontiers of medicine, from the digitome to advanced genomics via blockchain, AI and more
Digital & Marketing Prioritize tactics and tools to create powerful connections with customers through digital innovation
Medical Affairs Win back the trust of patients, payers and providers with a new lifecycle strategy that puts stakeholder value first
Digital Clinical Trials It’s time for new types of trial: democratized, patient-preferred, siteless and virtual
Market Access Create your value story for the next generation of pharma innovation and ensure patient access to life-changing care.
Diamond, Gold & Silver passes only
Free to biopharma
Free to biopharma
1200+ networkers Everyone in commercial pharma
1 conference app Connecting you with fellow attendees
Total interaction Roundtables, workshops and break-out sessions.
Other events say they attract senior executives - people with clout, budget, ideas and a mission. We really mean it. 1200 of them.
eyeforpharma Philadelphia attracts a global audience: a variety of job titles, geographies, cultures and opinions create a rich tapestry.
It’s not just about conference sessions. eyeforpharma Philadelphia is also home to a 80+ booth exhibition hall – packed with solutions to market access, commercial, digital, medical and clinical development challenges.
With the eyeforpharma Meeting & Messaging service, as a sponsor or exhibitor, you’ll be able to set up meetings with prospects and ensure your time onsite is as valuable as possible. Over 400 meetings were set up in 2019!
Join one of the 30+ discussions taking place on topics including digital marketing, commercial excellence, patient-centricity, market access, RWE and medical affairs.
Hear from healthcare innovators on the new technologies, ideas and science that is set to disrupt the very nature of healthcare and biopharma.
Grab a coffee and a pastry and recharge your batteries, and your phones!
Find out how digital clinical trials are disrupting clinical development and creating truly patient-centric trials.
Get in touch with the eyeforpharma team
Paul Simms Chairman
Blair Gottscho VP Operations
Izzy Gladstone VP Marketing
Karla Sharp Head of North America
Hannah Brady International Project Director
Saskia Burbach International Project Director
Liz Swift Head of Partnerships
Ed Harris Director, Business Development
Joseph Hargreaves Director, Business Development
Alex Norman Director, Business Development - Clinical